speb/financial-data huggingface dataset:
EMA.TO balance_sheet (annual, 2025-12-31) — Preferred Shares Number: 58000000.00
EMA.TO balance_sheet (quarterly, 2025-12-31) — Preferred Shares Number: 58000000.00
EMA.TO balance_sheet (annual, 2025-12-31) — Preferred Stock: 1422000000.00
EMA.TO balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 1422000000.00
EMA.TO cash_flow (annual, 2025-12-31) — Preferred Stock Dividend Paid: -75000000.00
EMA.TO cash_flow (quarterly, 2025-12-31) — Preferred Stock Dividend Paid: -19000000.00
EMA.TO income_statement (annual, 2025-12-31) — Preferred Stock Dividends: 75000000.00
EMA.TO income_statement (quarterly, 2025-12-31) — Preferred Stock Dividends: 19000000.00
EMA.TO balance_sheet (annual, 2025-12-31) — Preferred Stock Equity: 1422000000.00
EMA.TO balance_sheet (quarterly, 2025-12-31) — Preferred Stock Equity: 1422000000.00
EMA.TO balance_sheet (annual, 2025-12-31) — Prepaid Assets: 105000000.00
EMA.TO balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 105000000.00
EMA.TO income_statement (annual, 2025-12-31) — Pretax Income: 1171000000.00
EMA.TO income_statement (quarterly, 2025-12-31) — Pretax Income: 52000000.00
EMA.TO cash_flow (annual, 2025-12-31) — Purchase Of PPE: -3532000000.00
EMA.TO cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -966000000.00
EMA.TO balance_sheet (annual, 2025-12-31) — Receivables: 1753000000.00
EMA.TO balance_sheet (quarterly, 2025-12-31) — Receivables: 1753000000.00
EMA.TO balance_sheet (annual, 2025-12-31) — Receivables Adjustments Allowances: -15000000.00
EMA.TO balance_sheet (quarterly, 2025-12-31) — Receivables Adjustments Allowances: -15000000.00
EMA.TO income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 4942000000.00
EMA.TO income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 1274000000.00
EMA.TO income_statement (annual, 2025-12-31) — Reconciled Depreciation: 1298000000.00
EMA.TO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 335000000.00
EMA.TO cash_flow (annual, 2025-12-31) — Repayment Of Debt: -279000000.00
EMA.TO cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: 244000000.00
EMA.TO balance_sheet (annual, 2025-12-31) — Restricted Cash: 209000000.00
EMA.TO balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 209000000.00
EMA.TO balance_sheet (annual, 2025-12-31) — Retained Earnings: 1614000000.00
EMA.TO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 1614000000.00
EMA.TO cash_flow (annual, 2025-12-31) — Sale Of Business: 0.00
EMA.TO cash_flow (quarterly, 2025-12-31) — Sale Of Business: 0.00
EMA.TO balance_sheet (annual, 2025-12-31) — Share Issued: 301754258.00
EMA.TO balance_sheet (quarterly, 2025-12-31) — Share Issued: 301754258.00
EMA.TO cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 598000000.00
EMA.TO cash_flow (quarterly, 2025-12-31) — Short Term Debt Issuance: -387000000.00
EMA.TO cash_flow (annual, 2025-12-31) — Short Term Debt Payments: -78000000.00
EMA.TO cash_flow (quarterly, 2025-12-31) — Short Term Debt Payments: 269000000.00
EMA.TO income_statement (annual, 2025-12-31) — Special Income Charges: -11000000.00
EMA.TO income_statement (quarterly, 2025-12-31) — Special Income Charges: 17000000.00
EMA.TO balance_sheet (annual, 2025-12-31) — Stockholders Equity: 13382000000.00
EMA.TO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 13382000000.00
EMA.TO balance_sheet (annual, 2025-12-31) — Tangible Book Value: 6380000000.00
EMA.TO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 6380000000.00
EMA.TO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 980000.00
EMA.TO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 2850000.00
EMA.TO income_statement (annual, 2025-12-31) — Tax Provision: 81000000.00
EMA.TO income_statement (quarterly, 2025-12-31) — Tax Provision: -35000000.00
EMA.TO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.07
EMA.TO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.15
EMA.TO balance_sheet (annual, 2025-12-31) — Taxes Receivable: 103000000.00
EMA.TO balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 103000000.00
EMA.TO balance_sheet (annual, 2025-12-31) — Total Assets: 44817000000.00
EMA.TO balance_sheet (quarterly, 2025-12-31) — Total Assets: 44817000000.00
EMA.TO balance_sheet (annual, 2025-12-31) — Total Capitalization: 31835000000.00
EMA.TO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 31835000000.00
EMA.TO balance_sheet (annual, 2025-12-31) — Total Debt: 21461000000.00
EMA.TO balance_sheet (quarterly, 2025-12-31) — Total Debt: 21461000000.00
EMA.TO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 13396000000.00
EMA.TO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 13396000000.00
EMA.TO income_statement (annual, 2025-12-31) — Total Expenses: 6726000000.00
EMA.TO income_statement (quarterly, 2025-12-31) — Total Expenses: 1731000000.00
EMA.TO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 31421000000.00
EMA.TO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 31421000000.00
EMA.TO balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 40428000000.00
EMA.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 40428000000.00
EMA.TO balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 24794000000.00
EMA.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 24794000000.00
EMA.TO income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 1975000000.00
EMA.TO income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 275000000.00
EMA.TO income_statement (annual, 2025-12-31) — Total Other Finance Cost: 14000000.00
EMA.TO balance_sheet (annual, 2025-12-31) — Total Tax Payable: 19000000.00
EMA.TO balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 19000000.00
EMA.TO income_statement (annual, 2025-12-31) — Total Unusual Items: 14000000.00
EMA.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items: 19000000.00
EMA.TO income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 14000000.00
EMA.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 19000000.00
EMA.TO balance_sheet (annual, 2025-12-31) — Working Capital: -2238000000.00
EMA.TO balance_sheet (quarterly, 2025-12-31) — Working Capital: -2238000000.00
EMA.TO income_statement (annual, 2025-12-31) — Write Off: 0.00
EMA.TO income_statement (quarterly, 2025-12-31) — Write Off: -75000000.00
EMA.TO income_statement (quarterly, 2026-03-31) — +Operating Expense: 469000000.00
EMA.TO income_statement (quarterly, 2026-03-31) — +Total Revenue: 2813000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 1674000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 1110000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -11177000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 87000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 163000000.00
EMA.TO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 303300000.00
EMA.TO income_statement (quarterly, 2026-03-31) — Basic EPS: 1.85
EMA.TO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 371000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -879000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 11080000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 2457000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 2457000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -170000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 2208000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -872000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 735000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -315000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Change In Inventory: 23000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 145000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Change In Payable: -315000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -315000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Change In Receivables: 107000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -40000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Changes In Cash: 2071000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Common Stock: 9658000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -150000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 12768000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 198000000.00
EMA.TO income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 1401000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Current Assets: 6586000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Current Debt: 2751000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 2751000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 6176000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 118000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Deferred Tax: 118000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 337000000.00
EMA.TO income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 339000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 337000000.00
EMA.TO income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 339000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 95000000.00
EMA.TO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 304200000.00
EMA.TO income_statement (quarterly, 2026-03-31) — Diluted EPS: 1.85
EMA.TO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 561700000.00
EMA.TO income_statement (quarterly, 2026-03-31) — EBIT: 982000000.00
EMA.TO income_statement (quarterly, 2026-03-31) — EBITDA: 1321000000.00
EMA.TO income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest: 21000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Earnings Losses From Equity Investments: -5000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 37000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Employee Benefits: 270000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — End Cash Position: 2479000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Financial Assets: 41000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 2208000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -144000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -63000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 1069000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Goodwill: 5675000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 5675000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Gross PPE: 39447000000.00
EMA.TO income_statement (quarterly, 2026-03-31) — Gross Profit: 1412000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 215000000.00
EMA.TO income_statement (quarterly, 2026-03-31) — Interest Expense: 271000000.00
EMA.TO income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 271000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Inventory: 806000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 36725000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -872000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 638000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 198000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 2049000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Liabilities Heldfor Sale Non Current: 1048000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 21206000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 21206000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 2049000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -5000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 638000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Minority Interest: 14000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 198000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Net Debt: 21500000000.00
EMA.TO income_statement (quarterly, 2026-03-31) — Net Income: 582000000.00
EMA.TO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 561700000.00
EMA.TO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 582000000.00
EMA.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 582000000.00
EMA.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 582000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 582000000.00
EMA.TO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 582000000.00
EMA.TO income_statement (quarterly, 2026-03-31) — Net Interest Income: -271000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 2181000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 2044000000.00
EMA.TO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -271000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -1000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 7000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Net PPE: 28270000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -879000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: 137000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 8515000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Non Current Accounts Receivable: 568000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 333000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 2624000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 333000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 2624000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 270000000.00
EMA.TO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 1321000000.00
EMA.TO income_statement (quarterly, 2026-03-31) — Normalized Income: 582000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 735000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -78000000.00
EMA.TO income_statement (quarterly, 2026-03-31) — Operating Income: 943000000.00
EMA.TO income_statement (quarterly, 2026-03-31) — Operating Revenue: 2813000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 305783111.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 932000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 2751000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 1751000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 1069000000.00
EMA.TO income_statement (quarterly, 2026-03-31) — Other Income Expense: 39000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -184000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 3057000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 950000000.00
EMA.TO income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 18000000.00
EMA.TO income_statement (quarterly, 2026-03-31) — Other Taxes: 130000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Payables: 1674000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 1674000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Pension And Employee Benefit Expense: -10000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Preferred Shares Number: 58000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 1422000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Preferred Stock Dividend Paid: -20000000.00
EMA.TO income_statement (quarterly, 2026-03-31) — Preferred Stock Dividends: 20000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Preferred Stock Equity: 1422000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 124000000.00
EMA.TO income_statement (quarterly, 2026-03-31) — Pretax Income: 711000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -879000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Receivables: 1622000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Receivables Adjustments Allowances: -16000000.00
EMA.TO income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1403000000.00
EMA.TO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 337000000.00
EMA.TO cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -5000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 267000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 1954000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Share Issued: 305783111.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 14190000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 7093000000.00
EMA.TO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
EMA.TO income_statement (quarterly, 2026-03-31) — Tax Provision: 129000000.00
EMA.TO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.18
EMA.TO balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 119000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Total Assets: 48062000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 35396000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Total Debt: 23957000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 14204000000.00
EMA.TO income_statement (quarterly, 2026-03-31) — Total Expenses: 1870000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 33858000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 41476000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 27682000000.00
EMA.TO income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 943000000.00
EMA.TO balance_sheet (quarterly, 2026-03-31) — Working Capital: 410000000.00
EMAMILTD.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -4724835000.00
EMAMILTD.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 12785000.00
EMAMILTD.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -28058000.00
EMAMILTD.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 2405667000.00
EMAMILTD.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 444377648.00
EMAMILTD.NS income_statement (annual, 2022-03-31) — Basic EPS: 18.88
EMAMILTD.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 3866273000.00
EMAMILTD.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 5162000.00
EMAMILTD.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 270567000.00
EMAMILTD.NS cash_flow (annual, 2022-03-31) — Common Stock Dividend Paid: -3556110000.00
EMAMILTD.NS cash_flow (annual, 2022-03-31) — Common Stock Payments: -2000503000.00
EMAMILTD.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 444377648.00
EMAMILTD.NS income_statement (annual, 2022-03-31) — Diluted EPS: 18.88
EMAMILTD.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 22337000.00
EMAMILTD.NS balance_sheet (annual, 2022-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 737834000.00
EMAMILTD.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 1988199000.00
EMAMILTD.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 332984000.00
EMAMILTD.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 3237245000.00
EMAMILTD.NS balance_sheet (annual, 2022-03-31) — Hedging Assets Current: 29995000.00
EMAMILTD.NS income_statement (annual, 2022-03-31) — Interest Income: 277799000.00
EMAMILTD.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 277799000.00
EMAMILTD.NS balance_sheet (annual, 2022-03-31) — Investmentsin Associatesat Cost: 560650000.00
EMAMILTD.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 622047000.00
EMAMILTD.NS cash_flow (annual, 2022-03-31) — Long Term Debt Issuance: 2450792000.00
EMAMILTD.NS cash_flow (annual, 2022-03-31) — Long Term Debt Payments: -799659000.00
EMAMILTD.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 7291789000.00
EMAMILTD.NS cash_flow (annual, 2022-03-31) — Net Common Stock Issuance: -2000503000.00
EMAMILTD.NS balance_sheet (annual, 2022-03-31) — Net Debt: 2361383000.00
EMAMILTD.NS cash_flow (annual, 2022-03-31) — Net Foreign Currency Exchange Gain Loss: 0.00
EMAMILTD.NS cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: 1651133000.00
EMAMILTD.NS cash_flow (annual, 2022-03-31) — Net Other Investing Changes: 200000.00
EMAMILTD.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Revenue: 196390000.00
EMAMILTD.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 252313000.00
EMAMILTD.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 90372000.00
EMAMILTD.NS cash_flow (annual, 2022-03-31) — Other Cash Adjustment Outside Changein Cash: 665000.00
EMAMILTD.NS balance_sheet (annual, 2022-03-31) — Other Investments: 910000.00
EMAMILTD.NS balance_sheet (annual, 2022-03-31) — Other Payable: 78979000.00
EMAMILTD.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 345176000.00
EMAMILTD.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 1907404000.00
EMAMILTD.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
EMAMILTD.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 1526069000.00
EMAMILTD.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 68521000.00
EMAMILTD.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 68521000.00
EMAMILTD.NS cash_flow (annual, 2022-03-31) — Repurchase Of Capital Stock: -2000503000.00
EMAMILTD.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 29022000.00
EMAMILTD.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 11582972000.00
EMAMILTD.NS balance_sheet (annual, 2022-03-31) — Total Tax Payable: 173685000.00
EMAMILTD.NS balance_sheet (annual, 2022-03-31) — Treasury Shares Number: 0.00
EMAMILTD.NS balance_sheet (annual, 2022-03-31) — Work In Process: 61875000.00
EMAMILTD.NS income_statement (annual, 2022-03-31) — Write Off: 0.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — +Operating Expense: 15227322000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — +Total Revenue: 33620094000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 4071419000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 4146036000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -5521242000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 12785000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -110024000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Amortization: 1498920000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 1498920000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 1111250000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 441150000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Basic EPS: 14.50
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 275729000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 3912268000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -404588000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 168995000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 441150000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 467850000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 2986388000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -3529200000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 180911000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 286939000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Change In Inventory: 397905000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: 237782000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Change In Payable: -270130000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -313899000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -112422000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 284013000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Common Stock: 441150000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 23027999000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Common Stock Payments: -9934000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 76002000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 12237710000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Current Assets: 12868140000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 78510000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Current Debt: 736085000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 814595000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Current Deferred Taxes Liabilities: 256513000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 7238855000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 1281504000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Depreciation: 973570000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 2472490000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 2472490000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 973570000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 441150000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Diluted EPS: 14.50
EMAMILTD.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 6395720000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 29707000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Dividends Received Cfi: 12714000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — EBIT: 6769408000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — EBITDA: 9241898000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: -122961000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — End Cash Position: 467850000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 778205000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -6076449000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 1748955000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 7084171000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -439276000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -47419000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 481278000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Goodwill: 681900000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 5440079000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 4256060000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 12082501000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Gross Profit: 21382384000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Hedging Assets Current: 68280000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Interest Expense: 73914000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 73914000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Interest Income: 101224000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 101224000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -60031000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 77383000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Inventory: 3280393000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 23764084000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -1128297000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Investment Properties: 533890000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 1889455000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Investmentsin Associatesat Cost: 108677000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 2411294000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 617359000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 90485000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 90485000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 108677000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 277000000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 7476872000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Minority Interest: 99648000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Minority Interests: 121605000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: -28000000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: -9934000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Net Debt: 268235000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Net Income: 6395720000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 6395720000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 6274115000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 6395720000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 6395720000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 6695494000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 6274115000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Net Interest Income: 27310000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -889459000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -1901027000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: 27310000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Net Other Financing Charges: -465000000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Net PPE: 6561259000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -300935000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: -1901027000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 17587920000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 178172000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 3636767000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 134448000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 276992000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 42379000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 8767980000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Normalized Income: 5951627893.79
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 7488759000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Operating Income: 6155062000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Operating Revenue: 33620094000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 441150000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Other Cash Adjustment Outside Changein Cash: 31069000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 1680400000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 1000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 22586800000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 4758179000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Other Investments: 928000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: -26837000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 60900000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 161300000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 101397000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 2291786000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Other Payable: 76728000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Other Properties: 6485300000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 176139000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 2518538000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Other Special Charges: -47419000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Payables: 4345784000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 392313000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 1709190000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Pretax Income: 6695494000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 54681000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Purchase Of Business: -28000000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -21356923000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -404588000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 1484770000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 12237710000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 2472490000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 114020000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 114020000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -4312321000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Repurchase Of Capital Stock: -9934000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 501714000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 14400812000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 20467464000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 103653000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 6558106000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 7039384000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Share Issued: 441226228.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Short Term Debt Issuance: 2411294000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Short Term Debt Payments: -4312321000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Special Income Charges: 47419000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Stock Based Compensation: 0.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 23027999000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 17587920000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 29825893.79
EMAMILTD.NS income_statement (annual, 2023-03-31) — Tax Provision: 421379000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.06
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 6900000.00
EMAMILTD.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -1170437000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Total Assets: 31098520000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 23027999000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Total Debt: 905080000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 23127647000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Total Expenses: 27465032000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 7970873000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 18230380000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 732018000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 167930000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 473918000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 473918000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Treasury Shares Number: 76228.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Work In Process: 46668000.00
EMAMILTD.NS balance_sheet (annual, 2023-03-31) — Working Capital: 5629285000.00
EMAMILTD.NS income_statement (annual, 2023-03-31) — Write Off: 0.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — +Operating Expense: 15826898000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — +Total Revenue: 35302681000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 4545878000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 4942147000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -6275650000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 17435000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -162927000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Amortization: 931847000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 931800000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 909827000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 437265000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Basic EPS: 16.55
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 467850000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 4068821000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -405851000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 282667000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 436500000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 529539000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 4090360000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -3492000000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 120987000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 408552000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Change In Inventory: 46380000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: 72994000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Change In Payable: 586698000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -787729000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -337466000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 106402000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Common Stock: 436500000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 24465879000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Common Stock Payments: -2290970000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 96705000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 11821367000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Current Assets: 14182169000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 128348000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Current Debt: 656892000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 785240000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Current Deferred Taxes Liabilities: 244136000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 7588266000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 1102883000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Depreciation: 927200000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 1859000000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 1859059000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 927212000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 437265000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Diluted EPS: 16.55
EMAMILTD.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 7235297000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 31084000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Dividends Received Cfi: 12789000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — EBIT: 8008100000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — EBITDA: 9867159000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: -44713000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — End Cash Position: 529539000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 729153000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -5629695000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 1900128000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 7384207000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -181467000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: -41122000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 348027000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Goodwill: 681900000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 4522426000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 5105074000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 12474635000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Gross Profit: 23481314000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Hedging Assets Current: 66000000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Interest Expense: 99772000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 99772000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Interest Income: 125322000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 125322000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -99208000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 117755000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Inventory: 3234013000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 25122771000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -2053961000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Investment Properties: 519857000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 1638980000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Investmentsin Associatesat Cost: 1167826000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 333458000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 615135000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 154319000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 154319000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 1167826000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 153200000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 7693974000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Minority Interest: 111222000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Minority Interests: -6063000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: -945614000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: -2290970000.00
EMAMILTD.NS balance_sheet (annual, 2024-03-31) — Net Debt: 127353000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Net Income: 7235297000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 7235297000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 7241360000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 7235297000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 7235297000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 7908328000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 7241360000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Net Interest Income: 25550000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -800678000.00
EMAMILTD.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: -79193000.00
EMAMILTD.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: 25550000.00